Federation Of Spanish Scientific Medical Associations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Federation of spanish scientific medical associations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Federation Of Spanish Scientific Medical Associations Today - Breaking & Trending Today

Public Health Commission extends second AstraZeneca dose delay | Spanishvida

The Public Health Commission, in which all the autonomous communities and the Ministry of Health are represented, today agreed to extend the interval between the first and second doses of AstraZeneca from 12 to 16 weeks for people under 60 who have already received the first one. Expanding the interval will allow more information to ....

Public Health Commission , Federation Of Spanish Scientific Medical Associations , Ministry Of Health , Oxford University , Spanish Scientific Medical Associations , Vaccine Strategy ,

! Murcia Today - Spain Recommends Covid Vaccination For Pregnant Women

! Murcia Today - Spain Recommends Covid Vaccination For Pregnant Women
spanishnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spanishnewstoday.com Daily Mail and Mail on Sunday newspapers.

Spain General , Federation Of Spanish Scientific Medical Associations , Spain Ministry Of Health , Public Health Committee , Spanish Scientific Medical Associations , ஸ்பெயின் அமைச்சகம் ஆஃப் ஆரோக்கியம் , பொது ஆரோக்கியம் குழு , ஸ்பானிஷ் அறிவியல் மருத்துவ சங்கங்கள் ,

Public Health Commission extends second AstraZeneca dose delay

Posted on 2 days ago
5 min read
The Public Health Commission, in which all the autonomous communities and the Ministry of Health are represented, today agreed to extend the interval between the first and second doses of AstraZeneca from 12 to 16 weeks for people under 60 who have already received the first one. Expanding the interval will allow more information to be made available in order to make a decision that guarantees the safety of the vaccination, taking into account the best available knowledge, they say.

Thus, the published pharmacovigilance data on the use of the second dose of AZ in this age group and the new evidence on the use of a different vaccine for those who have received the first dose of AZ can be reviewed. In addition, the results of the Oxford University dose interchangeability study and other clinical trials such as the one initiated in Spain by the ISCIII will be available. ....

Federation Of Spanish Scientific Medical Associations , Ministry Of Health , Public Health Commission , Oxford University , Spanish Scientific Medical Associations , Vaccine Strategy , அமைச்சகம் ஆஃப் ஆரோக்கியம் , பொது ஆரோக்கியம் தரகு , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ஸ்பானிஷ் அறிவியல் மருத்துவ சங்கங்கள் , தடுப்பூசி மூலோபாயம் ,